Nobivac EDGE DAPPv is a 0.5 mL that provides protection against parainfluenza, distemper, adenovirus type 1, and parvovirus in one formula.

• Protects against all known strains of canine parvovirus (CPV), including CPV-2c
• Contains CPV-2b, one of the most prevalent field strains of parvovirus
• High antigenic mass (titer), low passage parvovirus vaccine
• Overrides CPV maternal antibodies in young puppies
• Protects against adenovirus type 1 that causes hepatitis in dogs
• Systemic administration stimulates a strong IgG response (CPiV)

Safety and Quality

• Lower total protein level than other 0.5 ml vaccine options
• Onderstepoort-type strain in Nobivac® vaccines provides a high level of safety (CDV)

• A porous filtration membrane selectively removes extraneous proteins, salts, and solvents
• Fewer total proteins (TP) means a more purified final product, which may reduce unwanted immune system responses such as vaccine reactions
• Promotes a higher level of vaccine quality
• Same process used for Nobivac® Lepto4, Nobivac®Canine-1 DAPPv+L4, and Nobivac EDGE™ Lepto4